DHL looks to strengthen presence in South American market

By Flora Southey

- Last updated on GMT


Related tags Logistics

Deutsche Post DHL Group’s contract logistics business, DHL Supply Chain, has announced its intention to acquire Brazilian transport service provider Polar Transportes. 

The São Paulo-based road carrier specialises in temperature-controlled transportation, enabling the shipment of biologic drugs and vaccines with temperature specifications.

Polar Transportes ships both Active Pharmaceutical Ingredients (APIs) and finished products to customers’ plants, from Brazilian ports and airports. Synthetic and biological drugs are among those currently transported under cold chain conditions.

DHL hopes the acquisition will strengthen its end-to-end offering for the Life Sciences and Healthcare industry in Brazil.

Polar Transportes has been working as a service provider for DHL for over 15 years. Its current network of 300 trucks allows national coverage, with greater circulation in São Paulo, Rio de Janeiro and the Goías State.

Acquiring control of our longstanding service provider Polar Transportes is…taking one more step to further foster our strong position in a key emerging market​,” said Javier Bilbao, CEO DHL Supply Chain Latin America.

While the financial terms of the acquisition have not been revealed, DHL has agreed to retain Polar Transportes’ current management team. Both companies are awaiting approval from the Brazilian competition authorities before the deal can be finalised.

The acquisition is in line with DHL’s interest in emerging markets. DHL Global Forwarding invested almost $1m (€935,462) in the market in 2016, and earlier this year announced the Group would be investing​ in four new temperature-controlled storage chambers in Puerto Rico. 

Related news

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us


View more